Results 11 to 20 of about 64,546 (199)

Intranasal Oxymetazoline and Xylometazoline Use in Patients With Deviated Nasal Septum: A Cross‐Sectional Telephone Survey [PDF]

open access: yesOTO Open
Objective To assess the pattern of oxymetazoline and xylometazoline (OXM) use in patients with deviated nasal septum (DNS). Study design A retrospective Computer‐Assisted Telephone Interviewing survey.
Marcin Masalski   +4 more
doaj   +2 more sources

Epidemiology and burden of nasal congestion

open access: yesInternational Journal of General Medicine, 2010
Michael Stewart1, BJ Ferguson2, Len Fromer31Department of Otorhinolaryngology, Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, USA; 2Department of Otolaryngology, University of Pittsburgh School of Medicine ...
Michael Stewart, BJ Ferguson, Len Fromer
doaj   +4 more sources

Clinical application and curative effects of continuous through-suture of the nasal septum for endoscopic septoplasty in randomised trials [PDF]

open access: yesHead & Face Medicine
Objectives To evaluate the clinical application and curative effect of continuous through-suture of the nasal septum (NS) of patients undergoing nasal septum correction surgery with nasal endoscopy.
Liyun Yang   +5 more
doaj   +2 more sources

Part 1 - imidazolines and the changing face of nasal decongestants [PDF]

open access: yesFrontiers in Pharmacology
Imidazolines are sympathomimetic drugs used to treat a range of conditions including nasal congestion, ocular disorders, and hypertension. Imidazolines were discovered over 150 years ago.
Rebecca J. Stinson, Laura R. Sadofsky
doaj   +2 more sources

Effectiveness of Prophylactic Intranasal Phenylephrine in Prevention of Nasal Congestion and Hypotension after Spinal Anaesthesia in Obstetric Patients: A Randomised Double Blinded Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Introduction: Spinal anaesthesia is an accepted technique in obstetric surgery but often associated with hypotension and nasal congestion. Phenylephrine, α1 agonist has been tried earlier in managing such adverse situations by parenteral route.
Sankar Roy   +2 more
doaj   +1 more source

Treating acute rhinitis and exacerbations of chronic rhinitis – A role for topical decongestants?

open access: yesSouth African Family Practice, 2020
Acute nasal symptoms are troublesome for patients. In addition, these symptoms are encountered frequently by individuals because of common infectious diseases, especially rhinovirus, giving rise to a ‘common cold’.
Robin J. Green   +5 more
doaj   +1 more source

Colds, flu and coughing: A review of over-the-counter nasal therapies in general practice

open access: yesSouth African Family Practice, 2013
Nasal congestion due to the common cold occurs because of dilation of the blood vessels, leading to swelling of the nasal mucosal epithelium. This narrows nasal passages, which are further blocked by increased mucus production. Nasal sprays and drops are
J. van Schoor
doaj   +1 more source

Nasal decongestants in monotherapy for the common cold [PDF]

open access: yes, 2016
Background : Many treatments for the common cold exist and are sold over-the-counter. Nevertheless, evidence on the effectiveness and safety of nasal decongestants is limited.
De Sutter, An   +4 more
core   +2 more sources

Management of severe epistaxis during pregnancy: a case report and review of the literature [PDF]

open access: yes, 2019
Epistaxis is a common problem during pregnancy. Few cases of severe epistaxis, not associated with nasal lesions or clotting disorders, were described in the literature.
Brunelli, Roberto   +6 more
core   +1 more source

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis [PDF]

open access: yes, 2004
BACKGROUND: Corticosteroids are considered to be particularly effective in reducing nasal congestion and are therefore recommended as first-line treatment in allergic rhinitis patients with moderate to severe and/or persistent symptoms.
Candore, G.   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy